Download FREE Report Sample
Download Free samplePirfenidone API Market contains market size and forecasts of Pirfenidone API in global, including the following market information:
Global Pirfenidone API Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Pirfenidone API Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Pirfenidone API companies in 2022 (%)
The global Pirfenidone API market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
0.99 Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pirfenidone API include Xian Libang Pharmaceutical, Metrochem API, Veranova, Alembic Pharmaceuticals Limited, Apotex Pharmachem, Aurobindo Pharma Limited, Cambrex Corporation, Glenmark Pharmaceuticals and Macleods Pharmaceuticals Limited, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pirfenidone API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pirfenidone API Market, by Purity, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pirfenidone API Market Segment Percentages, by Purity, 2022 (%)
0.99
0.995
0.999
Others
Global Pirfenidone API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pirfenidone API Market Segment Percentages, by Application, 2022 (%)
Tablets
Capsules
Others
Global Pirfenidone API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pirfenidone API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pirfenidone API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pirfenidone API revenues share in global market, 2022 (%)
Key companies Pirfenidone API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Pirfenidone API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Xian Libang Pharmaceutical
Metrochem API
Veranova
Alembic Pharmaceuticals Limited
Apotex Pharmachem
Aurobindo Pharma Limited
Cambrex Corporation
Glenmark Pharmaceuticals
Macleods Pharmaceuticals Limited
Mehta API
Natco Pharma Limited
Optimus Pharma
Shilpa Medicare
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy